Rhenman & Partners Asset Management Ab Medtronic PLC Transaction History

Rhenman & Partners Asset Management Ab

$1.01 Billion
Q2 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Medtronic PLC stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 208,000 shares of MDT stock, worth $18.6 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

208,000

Previous 325,000 36.0%

Holding current value

$18.6 Million

Previous $28.3 Million 42.2%

% of portfolio

1.62%

Previous 2.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$78.71 - $87.02 $9.21 Million - $10.2 Million	-117,000 Reduced 36.0%	208,000 $16.4 Million
Q1 2024 May 14, 2024	SELL	$82.84 - $88.09 $22 Million - $23.4 Million	-266,000 Reduced 45.01%	325,000 $28.3 Million
Q4 2023 Feb 13, 2024	BUY	$69.43 - $83.43 $15 Million - $18 Million	216,000 Added 57.6%	591,000 $48.7 Million
Q3 2023 Nov 13, 2023	SELL	$78.22 - $90.4 $1.96 Million - $2.26 Million	-25,000 Reduced 6.25%	375,000 $29.4 Million
Q3 2023 Nov 09, 2023	BUY	$78.22 - $90.4 $8.45 Million - $9.76 Million	108,000 Added 36.99%	400,000 $31.3 Million
Q2 2023 Aug 11, 2023	BUY	$79.47 - $91.38 $4.53 Million - $5.21 Million	57,000 Added 24.26%	292,000 $25.7 Million
Q1 2023 May 11, 2023	SELL	$76.72 - $87.58 $8.82 Million - $10.1 Million	-115,000 Reduced 32.86%	235,000 $18.9 Million
Q4 2022 Feb 13, 2023	BUY	$76.18 - $87.74 $8.38 Million - $9.65 Million	110,000 Added 45.83%	350,000 $27.2 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $7.27 Million - $8.58 Million	90,000 Added 60.0%	240,000 $21 Million
Q2 2022 Aug 12, 2022	SELL	$87.4 - $113.09 $874,000 - $1.13 Million	-10,000 Reduced 6.25%	150,000 $13.5 Million
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $13.7 Million - $15.3 Million	-136,000 Reduced 45.95%	160,000 $17.8 Million
Q4 2021 Feb 11, 2022	BUY	$99.53 - $127.75 $2.29 Million - $2.94 Million	23,000 Added 8.42%	296,000 $30.9 Million
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $7.33 Million - $8.15 Million	-62,000 Reduced 18.51%	273,000 $33.9 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $1.67 Million - $1.8 Million	15,000 Added 4.69%	335,000 $39.6 Million
Q4 2020 Jan 19, 2021	BUY	$100.57 - $117.14 $9.98 Million - $11.6 Million	99,220 Added 44.94%	320,000 $37.5 Million
Q3 2020 Oct 13, 2020	BUY	$90.13 - $108.78 $8.11 Million - $9.79 Million	90,000 Added 68.82%	220,780 $22.9 Million
Q1 2020 Apr 16, 2020	BUY	$72.92 - $121.3 $419,290 - $697,475	5,750 Added 4.6%	130,780 $11.8 Million
Q4 2019 Jan 17, 2020	SELL	$104.49 - $114.54 $6.29 Million - $6.89 Million	-60,188 Reduced 32.5%	125,030 $14.2 Million
Q3 2019 Oct 16, 2019	BUY	$98.02 - $111.18 $2.19 Million - $2.48 Million	22,335 Added 13.71%	185,218 $20.1 Million
Q2 2019 Jul 22, 2019	SELL	$84.15 - $99.38 $501,449 - $592,205	-5,959 Reduced 3.53%	162,883 $15.9 Million
Q1 2019 Apr 11, 2019	SELL	$82.45 - $93.79 $10.8 Million - $12.3 Million	-131,561 Reduced 43.79%	168,842 $15.4 Million
Q4 2018 Feb 05, 2019	BUY	$85.8 - $99.49 $4.34 Million - $5.03 Million	50,529 Added 20.22%	300,403 $27.3 Million
Q3 2018 Oct 03, 2018	SELL	$85.91 - $99.17 $2.58 Million - $2.98 Million	-30,000 Reduced 10.72%	249,874 $24.6 Million
Q2 2018 Jul 20, 2018	BUY	$77.48 - $87.83 $5.31 Million - $6.02 Million	68,591 Added 32.46%	279,874 $24 Million
Q1 2018 Apr 11, 2018	BUY	$76.55 - $87.26 $3.6 Million - $4.11 Million	47,058 Added 28.65%	211,283 $16.9 Million
Q4 2017 Jan 19, 2018	SELL	$76.93 - $83.5 $3.84 Million - $4.17 Million	-49,890 Reduced 23.3%	164,225 $13.3 Million
Q3 2017 Oct 13, 2017	BUY	$77.71 - $84.6 $16.6 Million - $18.1 Million	214,115	214,115 $16.7 Million

Others Institutions Holding MDT

# of Institutions

2,241

Shares Held

1.04B

Call Options Held

7.1M

Put Options Held

4.39M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Medtronic PLC Transaction History